Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: €4.3 M
• Last 3 months FTD volume: €8.45 M
• Last year FTD volume: €8.45 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€2.92 M	€32.37 M	🇺🇸 USA
Royalty Pharma RPRX	€21.63 M	€30.6 M	🇬🇧 UK
Palatin Technologies PTN	€2.38 M	€4.44 M	🇺🇸 USA
Eli Lilly LLY	€98.85 M	€0.23 B	🇺🇸 USA
AbbVie ABBV	€43.04 M	€0.20 B	🇺🇸 USA
Pfizer PFE	€24.22 M	€0.33 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	€2.31 M	€4.43 M	🇺🇸 USA
Athersys ATHX	€0.09 M	€0.71 M	🇺🇸 USA